Beate Stern

Founder at Uni Targeting Research AS

Consumer Services

Health Technology

Profile

Beate Stern is the founder of Uni Targeting Research AS, which was founded in 2001.
She held the title of Chief Scientific Officer at the company.
Currently, Dr. Stern is working as an Associate Professor at the University of Bergen.
In the past, she worked as a Principal at the Max-Planck-Institute for Molecular Genetics.

Beate Stern active positions

Companies	Position	Start
Uni Targeting Research AS Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway.	Founder	2009-07-27
University of Bergen	Corporate Officer/Principal	-

All active positions of Beate Stern

Former positions of Beate Stern

Companies	Position	End
Max-Planck-Institute for Molecular Genetics	Corporate Officer/Principal	-

See the detail of Beate Stern's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Beate Stern's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Uni Targeting Research AS Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway.	Health Technology